Ovation Science Strengthens IP with New Canadian Patent

Ovation Science Inc. announced the issuance of a new Canadian patent for its cannabinoid-based topical products. This development enhances the company's market exclusivity and the potential for licensing agreements. The patent covers proprietary formulations that deliver CBD and THC through the skin, leveraging Ovation's Invisicare® technology. This achievement strengthens Ovation's international patent portfolio, enhancing its position in the U.S. and Canadian cannabis markets.

The Invisicare® technology boosts cannabinoid absorption significantly compared to conventional methods, offering a competitive advantage. With four licensees already in place, Ovation is well-positioned for revenue growth in 2026. The company plans to capitalize on the evolving regulatory landscape in the U.S. and the growing demand for effective cannabinoid solutions. The patent aligns with Ovation's strategic goals of expanding its product range and exploring new market opportunities.